A unified nomenclature and amino acid numbering for human PTEN

Science Signaling

Volumn 7, Issue 332, 2014, Pages

  Pulido, Rafael ^a,b   Baker, Suzanne J ^c   Barata, Joao T ^d   Carracedo, Arkaitz ^a,e,f   Cid, Victor J ^g   Chin Sang, Ian D ^h   Davé, Vrushank ⁱ   Den Hertog, Jeroen ^j,k   Devreotes, Peter ^l   Eickholt, Britta J ^m   Eng, Charis ^n,o   Furnari, Frank B ^p   Georgescu, Maria Magdalena ^q   Gericke, Arne ^r   Hopkins, Benjamin ^s   Jiang, Xeujun ^t   Lee, Seung Rock ^u   Lösche, Mathias ^v,w   Malaney, Prerna ⁱ   Matias Guiu, Xavier ^x,y   Molina, María ^g   Pandolfi, Pier Paolo ^z   Parsons, Ramon ^s   Pinton, Paolo ^aa   Rivas, Carmen ^ab,ac   Rocha, Rafael M ^ad   Rodríguez, Manuel S ^ae   Ross, Alonzo H ^af   Serrano, Manuel ^ag   Stambolic, Vuk ^ah   Stiles, Bangyan ^ai   Suzuki, Akira ^aj   Tan, Seong Seng ^ak   Tonks, Nicholas K ^al   Trotman, Lloyd C ^al   Wolff, Nicolas ^am   Woscholski, Rudiger ^an   Wu, Hong ^ao,ap   Leslie, Nicholas R ^aq   more..

^a BASQUE FOUNDATION FOR SCIENCE   (Spain)

^b BIOCRUCES BIZKAIA HEALTH RESEARCH INSTITUTE   (Spain)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^e CIC BIOGUNE   (Spain)

^f UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^g UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^h QUEEN S UNIVERSITY   (Canada)

ⁱ H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^j UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^k LEIDEN UNIVERSITY   (Netherlands)

^l JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁿ LERNER RESEARCH INSTITUTE   (United States)

^o CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^r United States   (United States)

^s MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^t MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^u Chonnam National University Medical School   (South Korea)

^v CARNEGIE MELLON UNIVERSITY   (United States)

^w NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^x HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^y UNIVERSITY OF LLEIDA   (Spain)

^z HARVARD MEDICAL SCHOOL   (United States)

^aa UNIVERSITY OF FERRARA   (Italy)

^ab CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^ac UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^ad A C CAMARGO CANCER CENTER   (Brazil)

^ae San Sebastian Donostia   (Spain)

^af UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^ag Centro Nacional de Investigations Oncológicas   (Spain)

^ah UNIVERSITY HEALTH NETWORK   (Canada)

^ai UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^aj AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^ak UNIVERSITY OF MELBOURNE   (Australia)

^al Cold Spring Harbor Laboratory ^*  (United States)

^am INSTITUT PASTEUR   (France)

^an IMPERIAL COLLEGE LONDON   (United Kingdom)

^ao UNIVERSITY OF CALIFORNIA   (United States)

^ap Tsinghua University   (China)

^aq HERIOT WATT UNIVERSITY   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN; START CODON;

CATALYSIS; DATA BASE; HUMAN; NOMENCLATURE; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PUBLICATION; REVIEW; AMINO ACID SEQUENCE; CHEMISTRY; GENETICS; PROTEIN DATABASE; START CODON;

AMINO ACID SEQUENCE; AMINO ACIDS; CODON, INITIATOR; DATABASES, PROTEIN; HUMANS; PTEN PHOSPHOHYDROLASE; TERMINOLOGY AS TOPIC;

EID: 84903768994     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2005560     Document Type: Review

References (27)

1. D. M. Li, H. Sun, TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res. 57, 2124-2129 (1997).
2. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, S. I. Wang, J. Puc, C. Miliaresis, L. Rodgers, R. McCombie, S. H. Bigner, B. C. Giovanella, M. Ittmann, B. Tycko, H. Hibshoosh, M. H. Wigler, R. Parsons, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947 (1997).
3. P. A. Steck, M. A. Pershouse, S. A. Jasser, W. K. Yung, H. Lin, A. H. Ligon, L. A. Langford, M. L. Baumgard, T. Hattier, T. Davis, C. Frye, R. Hu, B. Swedlund, D. H. Teng, S. V. Tavtigian, Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15, 356-362 (1997).
4. M. S. Song, L. Salmena, P. P. Pandolfi, The functions and regulation of the PTEN tumour suppressor. Nat. Rev. Mol. Cell Biol. 13, 283-296 (2012).
5. M. C. Hollander, G. M. Blumenthal, P. A. Dennis, PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat. Rev. Cancer 11, 289-301 (2011).
6. J. Mester, C. Eng, When overgrowth bumps into cancer: The PTEN-opathies. Am. J. Med. Genet. C. Semin. Med. Genet. 163, 114-121 (2013).
7. J. Zhou, L. F. Parada, PTEN signaling in autism spectrum disorders. Curr. Opin. Neurobiol. 22, 873-879 (2012).
8. COSMIC (Catalogue of Somatic Mutations in Cancer), http://cancer.sanger. ac.uk/cancergenome/projects/cosmic/.
9. I. Rodríguez-Escudero, M. D. Oliver, A. Andrés-Pons, M. Molina, V. J. Cid, R. Pulido, A comprehensive functional analysis of PTEN mutations: Implications in tumor- and autism-related syndromes. Hum. Mol. Genet. 20, 4132-4142 (2011).
10. J. O. Lee, H. Yang, M. M. Georgescu, A. Di Cristofano, T. Maehama, Y. Shi, J. E. Dixon, P. Pandolfi, N. P. Pavletich, Crystal structure of the PTEN tumor suppressor: Implications for its phosphoinositide phosphatase activity and membrane association. Cell 99, 323-334 (1999).
11. B. D. Hopkins, B. Fine, N. Steinbach, M. Dendy, Z. Rapp, J. Shaw, K. Pappas, J. S. Yu, C. Hodakoski, S. Mense, J. Klein, S. Pegno, M. L. Sulis, H. Goldstein, B. Amendolara, L. Lei, M. Maurer, J. Bruce, P. Canoll, H. Hibshoosh, R. Parsons, A secreted PTEN phosphatase that enters cells to alter signaling and survival. Science 341, 399-402 (2013).
12. H. Liang, S. He, J. Yang, X. Jia, P. Wang, X. Chen, Z. Zhang, X. Zou, M. A. McNutt, W. H. Shen, Y. Yin, PTENα, a PTEN isoform translated through alternative initiation, regulates mitochondrial function and energy metabolism. Cell Metab. 19, 836-848 (2014).
13. P. Malaney, V. N. Uversky, V. Davé, The PTEN Long N-tail is intrinsically disordered: Increased viability for PTEN therapy. Mol. Biosyst. 9, 2877-2888 (2013).
14. A. Papa, L. Wan, M. Bonora, L. Salmena, M. S. Song, R. M. Hobbs, A. Lunardi, K. Webster, C. Ng, R. H. Newton, N. Knoblauch, J. Guarnerio, K. Ito, L. A. Turka, A. H. Beck, P. Pinton, R. T. Bronson, W. Wei, P. P. Pandolfi, Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function. Cell 157, 595-610 (2014).
15. H. Ishihara, T. Sasaoka, S. Kagawa, S. Murakami, K. Fukui, Y. Kawagishi, K. Yamazaki, A. Sato, M. Iwata, M. Urakaze, M. Ishiki, T. Wada, S. Yaguchi, H. Tsuneki, I. Kimura, M. Kobayashi, Association of the polymorphisms in the 52-untranslated region of PTEN gene with type 2 diabetes in a Japanese population. FEBS Lett. 554, 450-454 (2003).
16. M. Poetsch, T. Dittberner, C. Woenckhaus, PTEN/MMAC1 in malignant melanoma and its importance for tumor progression. Cancer Genet. Cytogenet. 125, 21-26 (2001).
17. M. Poetsch, G. Lorenz, B. Kleist, Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10. Cancer Genet. Cytogenet. 132, 20-24 (2002).
18. A. Sakai, C. Thieblemont, A. Wellmann, E. S. Jaffe, M. Raffeld, PTEN gene alterations in lymphoid neoplasms. Blood 92, 3410-3415 (1998).
19. B. Tunca, A. Bekar, G. Cecener, U. Egeli, O. Vatan, S. Tolunay, H. Kocaeli, K. Aksoy, Impact of novel PTEN mutations in Turkish patients with glioblastoma multiforme. J. Neurooncol. 82, 263-269 (2007).
20. N. R. Leslie, V. G. Brunton, Cell biology. Where is PTEN? Science 341, 355-356 (2013).
21. G. Denning, B. Jean-Joseph, C. Prince, D. L. Durden, P. K. Vogt, A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth. Oncogene 26, 3930-3940 (2007).
22. A. Gil, A. Andrés-Pons, E. Fernández, M. Valiente, J. Torres, J. Cervera, R. Pulido, Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs. Mol. Biol. Cell 17, 4002-4013 (2006).
23. S. M. Walker, N. R. Leslie, N. M. Perera, I. H. Batty, C. P. Downes, The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif. Biochem. J. 379, 301-307 (2004).
24. HGVS, www.hgvs.org/mutnomen/recs-prot.html.
25. L. Davidson, H. Maccario, N. M. Perera, X. Yang, L. Spinelli, P. Tibarewal, B. Glancy, A. Gray, C. J. Weijer, C. P. Downes, N. R. Leslie, Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN. Oncogene 29, 687-697 (2010).
26. T. Maehama, J. E. Dixon, The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375-13378 (1998).
27. M. P. Myers, I. Pass, I. H. Batty, J. Van der Kaay, J. P. Stolarov, B. A. Hemmings, M. H. Wigler, C. P. Downes, N. K. Tonks, The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc. Natl. Acad. Sci. U.S.A. 95, 13513-13518 (1998).